サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1508488

性感染症（STD）診断市場- 世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年

Sexually Transmitted Diseases (STD) Diagnostics Market [Type of Diagnostic Test: Molecular Test, Serologic Test, Point of Care Test, and Others (Immunological Test etc.)] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 157 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
性感染症（STD）診断市場- 世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年05月22日
発行: Transparency Market Research
ページ情報: 英文 157 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

性感染症（STD）診断市場- 調査範囲

TMRの調査レポート「性感染症（STD）診断の世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の性感染症（STD）診断市場の収益と予測を提供しています。また、2024年から2034年までの世界の性感染症（STD）診断市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、性感染症（STD）診断市場を理解しました。

市場スナップショット
2023年の市場規模 71億米ドル
2034年の市場規模 159億米ドル
CAGR 7.6%

当レポートでは、世界の性感染症（STD）診断市場の競合情勢について調査しています。世界の性感染症（STD）診断市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の性感染症（STD）診断市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測, 2020-2034年

第5章 主要洞察

  • 主要製品とブランドの分析
  • ポーターのファイブフォース分析
  • CDCの2022年性感染症（STI）監視
  • 低・中所得国における性感染症に関する考察

第6章 世界の市場分析と予測：診断検査タイプ別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：診断検査タイプ別, 2020-2034年
    • 分子検査
    • 血清学的検査
    • ポイントオブケアテスト
    • その他（免疫学的検査等）
  • 診断検査タイプ別の市場の魅力

第7章 世界の市場分析と予測：疾患別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：疾患タイプ別, 2020-2034年
    • クラミジア
    • 淋病
    • 梅毒
    • HIV/エイズ
    • ヒトパピローマウイルス（HPV）
    • 性器ヘルペス
    • その他性感染症
  • 疾病タイプ別の市場の魅力

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：エンドユーザー別, 2020-2034年
    • 病院・クリニック
    • 診断検査室
    • その他（研究機関、在宅ケア施設など）
  • エンドユーザー別の市場の魅力

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 市場シェア分析企業別（2023年）
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Hologic Inc.
    • Creative Diagnostics
    • Abbott Laboratories
    • Quest Diagnostics
    • BD
    • QIAGEN
    • Cepheid
    • bioMerieux
図表

List of Tables

  • Table 01: Global STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 02: Global STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 03: Global STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 04: Global STD Diagnostics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America STD Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 07: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 08: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 09: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 10: North America STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 11: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 12: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 13: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 14: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 15: North America STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 17: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 18: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 19: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 20: North America STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 21: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 23: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 24: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

List of Figures

  • Figure 01: Global STD Diagnostics Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global STD Diagnostics Market Value Share, by Type of Diagnostic Test, 2023
  • Figure 03: Global STD Diagnostics Market Value Share, by Disease Type, 2023
  • Figure 04: Global STD Diagnostics Market Value Share, by End-user, 2023
  • Figure 05: Global STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 06: Global STD Diagnostics Market Share Analysis, by Type of Diagnostic Test, 2022
  • Figure 07: Global STD Diagnostics Market Share Analysis, by Type of Diagnostic Test, 2031
  • Figure 08: Global STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 09: Global STD Diagnostics Market Value (US$ Mn), by Molecular Test, 2017-2031
  • Figure 10: Global STD Diagnostics Market Value Share Analysis, by Molecular Test, 2023 and 2034
  • Figure 11: Global STD Diagnostics Market Value (US$ Mn), by Serologic Test, 2017-2031
  • Figure 12: Global STD Diagnostics Market Value Share Analysis, by Serologic Test, 2023 and 2034
  • Figure 13: Global STD Diagnostics Market Value (US$ Mn), by Point of Care Test, 2017-2031
  • Figure 14: Global STD Diagnostics Market Value Share Analysis, by Point of Care Test, 2023 and 2034
  • Figure 15: Global STD Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 16: Global STD Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 17: Global STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 18: Global STD Diagnostics Market Share Analysis, by Disease Type, 2022
  • Figure 19: Global STD Diagnostics Market Share Analysis, by Disease Type, 2031
  • Figure 20: Global STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 21: Global STD Diagnostics Market Value (US$ Mn), by Clinical Disease Type, 2017-2031
  • Figure 22: Global STD Diagnostics Market Value Share Analysis, by Chlamydia, 2023 and 2034
  • Figure 23: Global STD Diagnostics Market Value (US$ Mn), by Gonorrhea, 2017-2031
  • Figure 24: Global STD Diagnostics Market Value Share Analysis, by Gonorrhea, 2023 and 2034
  • Figure 25: Global STD Diagnostics Market Value (US$ Mn), by Syphilis, 2017-2031
  • Figure 26: Global STD Diagnostics Market Value Share Analysis, by Syphilis, 2023 and 2034
  • Figure 27: Global STD Diagnostics Market Value (US$ Mn), by HIV/AIDS, 2017-2031
  • Figure 28: Global STD Diagnostics Market Value Share Analysis, by HIV/AIDS, 2023 and 2034
  • Figure 29: Global STD Diagnostics Market Value (US$ Mn), by Human Papillomavirus (HPV), 2017-2031
  • Figure 30: Global STD Diagnostics Market Value Share Analysis, by Human Papillomavirus (HPV), 2023 and 2034
  • Figure 31: Global STD Diagnostics Market Value (US$ Mn), by Genital Herpes, 2017-2031
  • Figure 32: Global STD Diagnostics Market Value Share Analysis, by Genital Herpes, 2023 and 2034
  • Figure 33: Global STD Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 34: Global STD Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 35: Global STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 36: Global STD Diagnostics Market Share Analysis, by End-user, 2022
  • Figure 37: Global STD Diagnostics Market Share Analysis, by End-user, 2031
  • Figure 38: Global STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 39: Global STD Diagnostics Market Value (US$ Mn), by Hospitals & Clinics, 2017-2031
  • Figure 40: Global STD Diagnostics Market Value Share Analysis, by Hospitals & Clinics, 2023 and 2034
  • Figure 41: Global STD Diagnostics Market Value (US$ Mn), by Diagnostic Laboratories, 2017-2031
  • Figure 42: Global STD Diagnostics Market Value Share Analysis, by Diagnostic Laboratories, 2023 and 2034
  • Figure 43: Global STD Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 44: Global STD Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 45: Global STD Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 46: Global STD Diagnostics Market Share Analysis, by Region, 2022
  • Figure 47: Global STD Diagnostics Market Share Analysis, by Region, 2031
  • Figure 48: Global STD Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 49: North America STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 50: North America STD Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 51: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 52: North America STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 53: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 54: North America STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 55: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 56: North America STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 57: Europe STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 58: Europe STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 59: Europe STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 60: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 61: North America STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 62: Europe STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 63: Europe STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 64: Europe STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Europe STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2020-2034
  • Figure 67: Asia Pacific STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Asia Pacific STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 70: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 71: Asia Pacific STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 72: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 73: Asia Pacific STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 74: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 75: Latin America STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 76: Latin America STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 77: Latin America STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 78: Latin America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 79: Latin America STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 80: Latin America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 81: Latin America STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 82: Latin America STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 83: Latin America STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 84: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 85: Middle East & Africa STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 86: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 87: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 88: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 89: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 90: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 91: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 92: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL1207

Sexually Transmitted Diseases (STD) Diagnostics Market - Scope of Report

TMR's report on the global sexually transmitted diseases (STD) diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global sexually transmitted diseases (STD) diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global sexually transmitted diseases (STD) diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the sexually transmitted diseases (STD) diagnostics market.

Market Snapshot
Market Value in 2023US$ 7.1 Bn
Market Value in 2034US$ 15.9 Bn
CAGR7.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global sexually transmitted diseases (STD) diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global sexually transmitted diseases (STD) diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global sexually transmitted diseases (STD) diagnostics market.

The report delves into the competitive landscape of the global sexually transmitted diseases (STD) diagnostics market. Key players operating in the global sexually transmitted diseases (STD) diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global sexually transmitted diseases (STD) diagnostics market profiled in this report.

Key Questions Answered in Global sexually transmitted diseases (STD) diagnostics Market Report:

  • What is the sales/revenue generated by sexually transmitted diseases (STD) diagnostics across all regions during the forecast period?
  • What are the opportunities in the global sexually transmitted diseases (STD) diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Sexually Transmitted Diseases (STD) Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global sexually transmitted diseases (STD) diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global sexually transmitted diseases (STD) diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global sexually transmitted diseases (STD) diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sexually Transmitted Diseases (STD) Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Key Product & Brand Analysis
  • 5.2. Porter's Five Forces Analysis
  • 5.3. CDC's 2022 Sexually Transmitted Disease (STI) Surveillance
  • 5.4. Insights on Sexually Transmitted Infections in Low and Middle Income Countries

6. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By Type of Diagnostic Test

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 6.3.1. Molecular Test
    • 6.3.2. Serologic Test
    • 6.3.3. Point of Care Test
    • 6.3.4. Others (Immunological Test etc.)
  • 6.4. Market Attractiveness By Type of Diagnostic Test

7. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By Disease Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Disease Type, 2020-2034
    • 7.3.1. Chlamydia
    • 7.3.2. Gonorrhea
    • 7.3.3. Syphilis
    • 7.3.4. HIV/AIDS
    • 7.3.5. Human Papillomavirus (HPV)
    • 7.3.6. Genital Herpes
    • 7.3.7. Others STDs
  • 7.4. Market Attractiveness By Disease Type

8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Others (Research Institutes, Homecare Settings etc.)
  • 8.4. Market Attractiveness By End-user

9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 10.2.1. Molecular Test
    • 10.2.2. Serologic Test
    • 10.2.3. Point of Care Test
    • 10.2.4. Others (Immunological Test etc.)
  • 10.3. Market Value Forecast By Disease Type, 2020-2034
    • 10.3.1. Chlamydia
    • 10.3.2. Gonorrhea
    • 10.3.3. Syphilis
    • 10.3.4. HIV/AIDS
    • 10.3.5. Human Papillomavirus (HPV)
    • 10.3.6. Genital Herpes
    • 10.3.7. Others STDs
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type of Diagnostic Test
    • 10.6.2. By Disease Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 11.2.1. Molecular Test
    • 11.2.2. Serologic Test
    • 11.2.3. Point of Care Test
    • 11.2.4. Others (Immunological Test etc.)
  • 11.3. Market Value Forecast By Disease Type, 2020-2034
    • 11.3.1. Chlamydia
    • 11.3.2. Gonorrhea
    • 11.3.3. Syphilis
    • 11.3.4. HIV/AIDS
    • 11.3.5. Human Papillomavirus (HPV)
    • 11.3.6. Genital Herpes
    • 11.3.7. Others STDs
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospitals & Clinics
    • 11.4.2. Diagnostic Laboratories
    • 11.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 11.5. Market Value Forecast By Country, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type of Diagnostic Test
    • 11.6.2. By Disease Type
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 12.2.1. Molecular Test
    • 12.2.2. Serologic Test
    • 12.2.3. Point of Care Test
    • 12.2.4. Others (Immunological Test etc.)
  • 12.3. Market Value Forecast By Disease Type, 2020-2034
    • 12.3.1. Chlamydia
    • 12.3.2. Gonorrhea
    • 12.3.3. Syphilis
    • 12.3.4. HIV/AIDS
    • 12.3.5. Human Papillomavirus (HPV)
    • 12.3.6. Genital Herpes
    • 12.3.7. Others STDs
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospitals & Clinics
    • 12.4.2. Diagnostic Laboratories
    • 12.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 12.5. Market Value Forecast By Country, 2020-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type of Diagnostic Test
    • 12.6.2. By Disease Type
    • 12.6.3. By End-user
    • 12.6.4. By Country

13. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 13.2.1. Molecular Test
    • 13.2.2. Serologic Test
    • 13.2.3. Point of Care Test
    • 13.2.4. Others (Immunological Test etc.)
  • 13.3. Market Value Forecast By Disease Type, 2020-2034
    • 13.3.1. Chlamydia
    • 13.3.2. Gonorrhea
    • 13.3.3. Syphilis
    • 13.3.4. HIV/AIDS
    • 13.3.5. Human Papillomavirus (HPV)
    • 13.3.6. Genital Herpes
    • 13.3.7. Others STDs
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospitals & Clinics
    • 13.4.2. Diagnostic Laboratories
    • 13.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 13.5. Market Value Forecast By Country, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type of Diagnostic Test
    • 13.6.2. By Disease Type
    • 13.6.3. By End-user
    • 13.6.4. By Country

14. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 14.2.1. Molecular Test
    • 14.2.2. Serologic Test
    • 14.2.3. Point of Care Test
    • 14.2.4. Others (Immunological Test etc.)
  • 14.3. Market Value Forecast By Disease Type, 2020-2034
    • 14.3.1. Chlamydia
    • 14.3.2. Gonorrhea
    • 14.3.3. Syphilis
    • 14.3.4. HIV/AIDS
    • 14.3.5. Human Papillomavirus (HPV)
    • 14.3.6. Genital Herpes
    • 14.3.7. Others STDs
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospitals & Clinics
    • 14.4.2. Diagnostic Laboratories
    • 14.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 14.5. Market Value Forecast By Country, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type of Diagnostic Test
    • 14.6.2. By Disease Type
    • 14.6.3. By End-user
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. F. Hoffmann-La Roche Ltd
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Thermo Fisher Scientific Inc.
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Hologic Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Creative Diagnostics
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Abbott Laboratories
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Quest Diagnostics
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. BD
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. QIAGEN
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Cepheid
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. bioMerieux
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview